NO20000811D0 - Method of selecting a drug - Google Patents
Method of selecting a drugInfo
- Publication number
- NO20000811D0 NO20000811D0 NO20000811A NO20000811A NO20000811D0 NO 20000811 D0 NO20000811 D0 NO 20000811D0 NO 20000811 A NO20000811 A NO 20000811A NO 20000811 A NO20000811 A NO 20000811A NO 20000811 D0 NO20000811 D0 NO 20000811D0
- Authority
- NO
- Norway
- Prior art keywords
- drug
- selecting
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N2333/245—Escherichia (G)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9717652.3A GB9717652D0 (en) | 1997-08-20 | 1997-08-20 | Method |
| PCT/GB1998/002504 WO1999009416A2 (en) | 1997-08-20 | 1998-08-20 | Method of drug selection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000811D0 true NO20000811D0 (en) | 2000-02-18 |
| NO20000811L NO20000811L (en) | 2000-04-12 |
Family
ID=10817781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000811A NO20000811L (en) | 1997-08-20 | 2000-02-18 | Procedure for drug selection |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1005655A2 (en) |
| JP (1) | JP2001516029A (en) |
| AU (2) | AU8817398A (en) |
| CA (1) | CA2300903A1 (en) |
| GB (1) | GB9717652D0 (en) |
| NO (1) | NO20000811L (en) |
| WO (2) | WO1999009417A2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9809782D0 (en) * | 1998-05-07 | 1998-07-08 | Nycomed Imaging As | Method |
| GB9809780D0 (en) * | 1998-05-07 | 1998-07-08 | Nycomed Imaging As | Method |
| GB9809776D0 (en) | 1998-05-07 | 1998-07-08 | Nycomed Imaging As | Method |
| WO2008106429A2 (en) | 2007-02-26 | 2008-09-04 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of heart failure and other disorders |
| CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
| CN105658661B (en) * | 2013-02-20 | 2020-07-24 | 卑尔根技术交易股份公司 | Vaccine |
| EP3841111A1 (en) | 2018-08-24 | 2021-06-30 | Vestlandets Innovasjonsselskap AS | Heat-stable enterotoxins mutants as antidiarrheal vaccine antigens |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5075211A (en) * | 1986-03-26 | 1991-12-24 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
| US4965343A (en) * | 1988-01-28 | 1990-10-23 | Hoffmann-La Roche Inc. | Method of peptide synthesis |
| JPH0768271B2 (en) * | 1989-08-31 | 1995-07-26 | 三菱化学株式会社 | Method for producing human osteocalcin |
| CS89491A3 (en) * | 1990-04-09 | 1992-01-15 | Chugai Pharmaceutical Co Ltd | Hybrid calcitonin |
| US5723286A (en) * | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
| US5824483A (en) * | 1994-05-18 | 1998-10-20 | Pence Inc. | Conformationally-restricted combinatiorial library composition and method |
| US5911997A (en) * | 1995-06-07 | 1999-06-15 | Connetics Corporation | Relaxin-like factor and methods and uses thereof |
| WO1997022617A1 (en) * | 1995-12-18 | 1997-06-26 | Praecis Pharmaceuticals Incorporated | Methods for identifying compounds that bind to a target |
-
1997
- 1997-08-20 GB GBGB9717652.3A patent/GB9717652D0/en active Pending
-
1998
- 1998-08-20 JP JP2000510029A patent/JP2001516029A/en not_active Withdrawn
- 1998-08-20 CA CA002300903A patent/CA2300903A1/en not_active Abandoned
- 1998-08-20 AU AU88173/98A patent/AU8817398A/en not_active Abandoned
- 1998-08-20 AU AU88168/98A patent/AU8816898A/en not_active Abandoned
- 1998-08-20 EP EP98939765A patent/EP1005655A2/en not_active Withdrawn
- 1998-08-20 WO PCT/GB1998/002510 patent/WO1999009417A2/en not_active Ceased
- 1998-08-20 WO PCT/GB1998/002504 patent/WO1999009416A2/en not_active Ceased
-
2000
- 2000-02-18 NO NO20000811A patent/NO20000811L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999009417A3 (en) | 1999-08-12 |
| WO1999009416A3 (en) | 1999-10-21 |
| GB9717652D0 (en) | 1997-10-22 |
| WO1999009417A2 (en) | 1999-02-25 |
| WO1999009416A2 (en) | 1999-02-25 |
| JP2001516029A (en) | 2001-09-25 |
| AU8816898A (en) | 1999-03-08 |
| EP1005655A2 (en) | 2000-06-07 |
| CA2300903A1 (en) | 1999-02-25 |
| NO20000811L (en) | 2000-04-12 |
| WO1999009417A9 (en) | 1999-05-27 |
| AU8817398A (en) | 1999-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26549A1 (en) | DRUGS | |
| NO994757L (en) | Method for Oral Administration of Proteins | |
| FI963984L (en) | New oral pharmaceutical dosage form | |
| FI973243L (en) | New pharmaceutical combination | |
| ID19343A (en) | DRUG POWDER INHUB | |
| EP0898978A4 (en) | ASPIRATION TYPE DRUG APPLICATOR | |
| FI971279L (en) | Drug | |
| EE03925B1 (en) | Method for the preparation of a pharmacologically active substance | |
| FR2767121B1 (en) | DISTRIBUTOR OF DRUGS | |
| NO995251D0 (en) | Procedure for administering halotherapy | |
| NO20042393L (en) | Polymorph of a drug | |
| BR9610214A (en) | Pharmaceutical compounds | |
| DK0868911T3 (en) | Rapamycin preparations for oral administration | |
| NO975660D0 (en) | Use of benzimidazoles for the manufacture of a drug for the treatment of liver chemistry | |
| BR9600809A (en) | Medication | |
| BR9607626A (en) | New pharmaceutical naphthyl compounds | |
| NO973610D0 (en) | New pharmaceutical preparation | |
| GB9508823D0 (en) | Drug Derivatives | |
| NO20000811D0 (en) | Method of selecting a drug | |
| EE03384B1 (en) | Use of melatonin for the manufacture of a medicament | |
| NO994083D0 (en) | Selective epoxidation method for the preparation of pharmaceutical compounds | |
| NO973611D0 (en) | New pharmaceutical preparation | |
| EE200000401A (en) | Process for the preparation of a pharmaceutical preparation | |
| DK0866699T3 (en) | Use of cholinesterase inhibitors for the manufacture of a medicament for the treatment of xerostomy | |
| NO965448L (en) | Pharmaceutical compounds |